Affiliation:
1. Department of Surgery, UCLA School of Medicine, Los Angeles, California, USA
Abstract
Endovascular exclusion of abdominal aortic aneurysms (AAAs) is an investigational technique under scrutiny around the world. The tube and bifurcated versions of the Endovascular Grafting System (EGS) developed by Endovascular Technologies are the subjects of FDA-approved multicenter trials in the United States (US). Similar studies are under way in Europe, Australia, and the United Kingdom. This review details the implantation techniques for the EGS device and summarizes the important clinical findings published through 1996. Although the EGS was voluntarily removed from the US trial when fractures were discovered in the graft attachment system, subsequent experience with the re-engineered EGS has been positive. Successfully implanted EGS tube grafts have been associated with aneurysm shrinkage after 1 year in AAAs initially excluded or with sealed endoleaks. Aneurysm enlargement has been seen in EGS tube grafts with persistent endoleak.
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,Surgery
Reference11 articles.
1. Endovascular Grafting for the Treatment of Abdominal Aortic Aneurysms
2. Moore WS. Endovascular grafting technique: A feasibility study. In: Yao JST, Pearce WH eds. Aneurysms: New Findings and Treatments. Norwalk, CT, Appleton and Lange, 1993:333–340.
3. Repair of Abdominal Aortic Aneurysm by Transfemoral Endovascular Graft Placement
4. Moore WS. Transfemoral endovascular repair of abdominal aortic aneurysm using the endovascular graft system device. In: Greenhalgh RM ed. Vascular and Endovascular Surgical Techniques: An Atlas, 3rd ed. Philadelphia, WB Saunders, 1994:78–91.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献